Below is a report from IP Organisers (an independent service company of Phillips Ormonde Fitzpatrick) detailing Australian Pharmaceutical Patents (that have been granted extensions) and that are due to expire in the coming month.
This report covers 2 Australian patents whose Extension of Term expires in January 2014. Best wishes for the holiday season and new year from the team at IP Organisers!
|
Australian Pharmaceutical Patents
Expiring January 2014
www.iporganisers.com/pharma/january2014.htm
|
| Active Ingredients |
Enalapril maleate; Hydrochlorothiazide |
| Trade Name |
Renitec Plus |
| Chemical Name |
(S)-1-[N-[1-(ethoxycarbonyl)-3-phenylpropyl]-L-alanyl]-L-proline, (Z)-2-butenedioate salt (1:1) | 6-chloro-3,4-dihydro-2H-1,2,4-benzo-thiadiazine-7-sulfonamide 1,1-dioxide |
| Chemical Structure |
  |
| Australian Patent |
AU-B-686097 |
| Expiry Date |
7 January 2014 |
| Patent Assignee |
Merck Sharp & Dohme Corp. |
| Title |
Combinations of ACE inhibitors and diuretics |
| Abstract |
Pharmaceutical formulations comprising as active ingredients an angiotensin converting enzyme (ACE) inhibitor at a dose level normally found effective as an antihypertensive and a diuretic at a dose level below its minimum effective dose, demonstrate greater efficacy than would be expected in returning the blood pressure of hypertensive patients to normotensive values. |
| Australian Register of Therapeutic Goods |
ARTG ID 67439 |
| Consumer Medicine Information |
Renitec Plus (Enalapril maleate; Hydrochlorothiazide) |
| Product Information |
Renitec Plus (Enalapril maleate; Hydrochlorothiazide) |
| Active Ingredient |
Tolterodine tartrate |
| Trade Name |
Detrusitol |
| Chemical Name |
(R)-N,N-diisopropyl-3-(2-hydroxy-5-methylphenyl)-3-phenylpropanamine L-hydrogen tartrate |
| Chemical Structure |
 |
| Australian Patent |
AU-B-635493 |
| Expiry Date |
20 January 2014 |
| Patent Assignee |
Pharmacia & Upjohn AB |
| Title |
New amines, their use and preparation |
| Abstract |
Novel 3,3-diphenylpropylamines of formula (I) wherein R1 signifies hydrogen or methyl, R2, R3 and R4 independently signify hydrogen, methyl, methoxy, hydroxy, carbamoyl, sulphanoyl or halogen, and X represents a tertiary amino group -NR5, R6, wherein R5 and R6signify non-aromatic hydrocarbyl groups, which may be the same or different and which together contain at least three carbon atoms, and which may form a ring together with the amine nitrogen, their salts with physiologically acceptable acids and, when the compounds can be in the form of optical isomers, the racemic mixture and the individual enantiomers, their use as drugs, especially as anticholinergic agents, their use for preparing an anticholinergic drug, pharmaceutical compositions containing the novel amines, and methods for preparing the same. |
| Australian Register of Therapeutic Goods |
ARTG ID 99393ARTG ID 99394 |
| Consumer Medicine Information |
Detrusitol (Tolterodine tartrate) |
| Product Information |
Detrusitol (Tolterodine tartrate) |
For further information please contact Rodney Chiang-Cruise or Aaron McMillan at IP Organisers Pty Ltd
|
